Previous biomarker research usually adopted MSA as a part of parkinsonism and observed the performance of several fluid markers such as glial fibrillary acidic protein (GFAP), phosphorylated tau (p-tau), and amyloid-β (Aβ)7,8. This evidence concerns the gene MAPT and Parkinson disease.